Annual EBIT
-$27.93 M
+$281.00 K+1.00%
31 December 2023
Summary:
Profound Medical annual earnings before interest & taxes is currently -$27.93 million, with the most recent change of +$281.00 thousand (+1.00%) on 31 December 2023. During the last 3 years, it has fallen by -$6.89 million (-32.77%). PROF annual EBIT is now -237.68% below its all-time high of -$8.18 million.PROF EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$8.99 M
-$1.16 M-14.75%
01 September 2024
Summary:
Profound Medical quarterly earnings before interest & taxes is currently -$8.99 million, with the most recent change of -$1.16 million (-14.75%) on 01 September 2024. Over the past year, it has dropped by -$2.43 million (-37.01%). PROF quarterly EBIT is now -108189.16% below its all-time high of -$8300.00, reached on 31 December 2014.PROF Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$32.40 M
-$2.43 M-8.10%
01 September 2024
Summary:
Profound Medical TTM earnings before interest & taxes is currently -$32.40 million, with the most recent change of -$2.43 million (-8.10%) on 01 September 2024. Over the past year, it has dropped by -$7.66 million (-30.96%). PROF TTM EBIT is now -11688.94% below its all-time high of -$274.80 thousand, reached on 30 September 2014.PROF TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PROF EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1.0% | -37.0% | -31.0% |
| 3 y3 years | -32.8% | -51.8% | -14.8% |
| 5 y5 years | -95.0% | -102.3% | -145.3% |
PROF EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -32.8% | +8.5% | -83.3% | +11.8% | -31.0% | +0.3% |
| 5 y | 5 years | -99.0% | +8.5% | -328.8% | +11.8% | -145.3% | +0.3% |
| alltime | all time | -237.7% | +8.5% | <-9999.0% | +11.8% | <-9999.0% | +0.3% |
Profound Medical EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$8.99 M(+14.7%) | -$32.40 M(+8.1%) |
| June 2024 | - | -$7.83 M(+4.7%) | -$29.97 M(+4.9%) |
| Mar 2024 | - | -$7.48 M(-7.5%) | -$28.57 M(+2.3%) |
| Dec 2023 | -$27.93 M(-1.0%) | -$8.09 M(+23.4%) | -$27.93 M(+12.9%) |
| Sept 2023 | - | -$6.56 M(+1.9%) | -$24.74 M(-6.3%) |
| June 2023 | - | -$6.44 M(-5.9%) | -$26.41 M(+2.1%) |
| Mar 2023 | - | -$6.84 M(+39.4%) | -$25.87 M(-4.9%) |
| Dec 2022 | -$28.21 M(-7.6%) | -$4.90 M(-40.4%) | -$27.20 M(-16.3%) |
| Sept 2022 | - | -$8.23 M(+39.6%) | -$32.49 M(+7.7%) |
| June 2022 | - | -$5.90 M(-27.8%) | -$30.18 M(-3.4%) |
| Mar 2022 | - | -$8.17 M(-19.9%) | -$31.25 M(+2.4%) |
| Dec 2021 | -$30.53 M(+45.1%) | -$10.19 M(+72.1%) | -$30.53 M(+8.1%) |
| Sept 2021 | - | -$5.92 M(-15.0%) | -$28.23 M(+0.1%) |
| June 2021 | - | -$6.96 M(-6.5%) | -$28.21 M(+6.9%) |
| Mar 2021 | - | -$7.45 M(-5.6%) | -$26.39 M(+25.5%) |
| Dec 2020 | -$21.03 M(+49.8%) | -$7.89 M(+33.8%) | -$21.03 M(+26.2%) |
| Sept 2020 | - | -$5.90 M(+14.7%) | -$16.67 M(+9.6%) |
| June 2020 | - | -$5.14 M(+145.4%) | -$15.21 M(+6.8%) |
| Mar 2020 | - | -$2.10 M(-40.6%) | -$14.24 M(+1.3%) |
| Dec 2019 | -$14.04 M | -$3.53 M(-20.7%) | -$14.05 M(+6.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | -$4.44 M(+6.5%) | -$13.21 M(+5.5%) |
| June 2019 | - | -$4.17 M(+118.4%) | -$12.52 M(+0.1%) |
| Mar 2019 | - | -$1.91 M(-28.7%) | -$12.51 M(-12.2%) |
| Dec 2018 | -$14.32 M(+3.5%) | -$2.68 M(-28.7%) | -$14.25 M(+1.7%) |
| Sept 2018 | - | -$3.76 M(-9.7%) | -$14.00 M(-4.0%) |
| June 2018 | - | -$4.16 M(+14.0%) | -$14.59 M(+5.5%) |
| Mar 2018 | - | -$3.65 M(+49.8%) | -$13.83 M(+6.0%) |
| Dec 2017 | -$13.84 M(+20.1%) | -$2.44 M(-43.9%) | -$13.05 M(-6.8%) |
| Sept 2017 | - | -$4.34 M(+27.6%) | -$14.00 M(+11.9%) |
| June 2017 | - | -$3.40 M(+18.9%) | -$12.51 M(+6.7%) |
| Mar 2017 | - | -$2.86 M(-15.6%) | -$11.72 M(+1.1%) |
| Dec 2016 | -$11.52 M(+39.3%) | -$3.39 M(+18.7%) | -$11.60 M(+18.5%) |
| Sept 2016 | - | -$2.86 M(+9.2%) | -$9.79 M(+9.5%) |
| June 2016 | - | -$2.61 M(-4.5%) | -$8.93 M(-11.8%) |
| Mar 2016 | - | -$2.74 M(+73.3%) | -$10.13 M(+36.8%) |
| Dec 2015 | -$8.27 M | -$1.58 M(-21.2%) | -$7.41 M(+26.9%) |
| Sept 2015 | - | -$2.00 M(-47.4%) | -$5.84 M(+42.1%) |
| June 2015 | - | -$3.81 M(>+9900.0%) | -$4.11 M(+1297.3%) |
| Mar 2015 | - | -$10.80 K(+30.1%) | -$293.90 K(+3.8%) |
| Dec 2014 | - | -$8300.00(-97.0%) | -$283.10 K(+3.0%) |
| Sept 2014 | - | -$274.80 K | -$274.80 K |
FAQ
- What is Profound Medical annual earnings before interest & taxes?
- What is the all time high annual EBIT for Profound Medical?
- What is Profound Medical annual EBIT year-on-year change?
- What is Profound Medical quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Profound Medical?
- What is Profound Medical quarterly EBIT year-on-year change?
- What is Profound Medical TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Profound Medical?
- What is Profound Medical TTM EBIT year-on-year change?
What is Profound Medical annual earnings before interest & taxes?
The current annual EBIT of PROF is -$27.93 M
What is the all time high annual EBIT for Profound Medical?
Profound Medical all-time high annual earnings before interest & taxes is -$8.18 M
What is Profound Medical annual EBIT year-on-year change?
Over the past year, PROF annual earnings before interest & taxes has changed by +$281.00 K (+1.00%)
What is Profound Medical quarterly earnings before interest & taxes?
The current quarterly EBIT of PROF is -$8.99 M
What is the all time high quarterly EBIT for Profound Medical?
Profound Medical all-time high quarterly earnings before interest & taxes is -$8300.00
What is Profound Medical quarterly EBIT year-on-year change?
Over the past year, PROF quarterly earnings before interest & taxes has changed by -$2.43 M (-37.01%)
What is Profound Medical TTM earnings before interest & taxes?
The current TTM EBIT of PROF is -$32.40 M
What is the all time high TTM EBIT for Profound Medical?
Profound Medical all-time high TTM earnings before interest & taxes is -$274.80 K
What is Profound Medical TTM EBIT year-on-year change?
Over the past year, PROF TTM earnings before interest & taxes has changed by -$7.66 M (-30.96%)